2021-032 Yan'an Pharmaceutical: Announcement of Resolutions of the Second Extraordinary General Meeting of Shareholders in 2021
classification: Notice
Time:2021-10-25 16:41
1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: September 15, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site
4. Convener of the meeting: Board of Directors
5. Moderator of the meeting: Chairman Wang Xueliang
6. Explanation of legality, compliance, and constitutionality of the convening situation:
The procedures for convening, convening, and reviewing proposals are in compliance with the "Company Law" and "Articles of Association" and the relevant provisions of the company's management system on the convening of general meetings of shareholders, and the resolutions made are legal and valid.
(2) Meeting attendance
A total of 12 shareholders attended and authorized to attend this general meeting, with a total of 116,129,000 voting shares, accounting for 92.17% of the company's total voting shares.
(3) The company's directors, supervisors, and senior management personnel attending or attending the general meeting of shareholders as non-voting delegates
1. There are 7 incumbent directors of the company and 7 people attended;
2. 3 of the company’s current supervisors and 2 were present. Supervisor Wang Haiyan was absent due to personal reasons (if applicable);
3. The secretary of the company's board of directors attended the meeting;
Senior executives of the company Wang Xueliang, Yuan Zhao, Zhang Wei, Zhao Junling, Tao Xu, Cai Liying and Qu Shen attended the meeting as non-voting delegates.
2. Review of the proposal
(1) Deliberated and approved the "Proposal on the Company's Proposal to Dissolve the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd."
1. The content of the proposal:
Based on the company's development needs, the company plans to terminate the continuous supervision agreement after full communication and friendly negotiation with Guotai Junan Securities Co., Ltd. and reach an agreement on termination related matters. Guotai Junan Securities Co., Ltd. will no longer serve as the company's continuous supervision of the main brokerage firm after this change has been approved by the National SME Share Transfer System.
2. The result of the voting on the proposal:
116,129,000 shares agreed, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for the total number of shares with voting rights in this general meeting 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
(2) Deliberated and approved the "Proposal on the Explanatory Report on the Termination of the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd."
1. The content of the proposal:
In accordance with relevant regulations such as the "Guidelines for the Consultation of the Leading Securities Dealers and Listed Companies in the National SME Share Transfer System to Resolve the Continuous Supervision Agreement" The transfer system submitted the "Explanatory Report on the Termination of the Continuous Supervision Agreement with Guotai Junan Securities Co., Ltd.".
2. The result of the voting on the proposal:
116,129,000 shares agreed, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for the total number of shares with voting rights in this general meeting 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
(3) Deliberated and approved the "Proposal on the Company's Proposal to Sign a Continuous Supervision Agreement with Tianfeng Securities Co., Ltd."
1. The content of the proposal:
Based on the company's development needs, and in accordance with the relevant requirements and regulations of the China Securities Regulatory Commission and the National SME Share Transfer System, the company plans to sign the "Continuing Supervision Agreement" with Tianfeng Securities Co., Ltd. After this continuous supervision of the change of the main brokerage firm is reviewed and approved by the National SME Share Transfer System, Tianfeng Securities Co., Ltd. will take over the main brokerage firm and perform its continuous supervision obligations.
2. The result of the voting on the proposal:
116,129,000 shares agreed, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for the total number of shares with voting rights in this general meeting 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
(4) Deliberated and approved the "Proposal on Authorizing the Board of Directors to Fully Manage Matters Concerning the Continuous Supervision of the Change of the Leading Securities Dealer"
1. The content of the proposal:
In order to ensure the company's successful completion of this continuous supervision of the host brokerage change, it is proposed to authorize the company's board of directors to be fully responsible for the company's continuous supervision of the host brokerage change. The specific scope of authorization includes the declaration of relevant documents and information to the National SME Share Transfer System Company for the continuous supervision of the host brokerage change, approval and signing of the documents and contracts related to the continuous supervision of the host brokerage change, and the handling of the continuous supervision of the host brokerage company. All other matters related to the change.
2. The result of the voting on the proposal:
116,129,000 shares agreed, accounting for 100% of the total number of shares with voting rights in this general meeting; 0 shares opposed, accounting for 0% of the total number of shares with voting rights in this general meeting; 0 shares abstained, accounting for the total number of shares with voting rights in this general meeting 0% of the total number of voting shares.
3. Avoid voting
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
3. List of available documents
1. Resolutions of the second extraordinary general meeting of shareholders of Shanghai Yanan Pharmaceutical Yangpu Co., Ltd. in 2021
Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
September 16, 2021